Bristol Myers Squibb raises quarterly dividend and adds $15 billion to share buyback program


Bristol Myers Squibb Co. shares

rose 2% in premarket trade Monday, after the company announced a 10.2% increase in its quarterly dividend and added $15 billion to its share buyback authorization. The new dividend of 54 cents a share will be payable Feb. 1, 2022 to shareholders of record as of Jan. 7. The company also declared a quarterly dividend of 50 cents a share for its $2.00 convertible preferred stock, payable March 1 to shareholders of record as of Feb. 1. The new share buyback authorization increases the current amount to about $15.2 billion. Shares are down 9% in the year to date, while the S&P 500

has gained 25%.

Pfizer to Buy Arena Pharmaceuticals in $6.7 Billion Deal. Arena Stock Soars.

Previous article

Analysts: Pfizer to ‘capitalize’ on experimental colitis treatment in Arena deal

Next article

You may also like


Leave a reply

Your email address will not be published.

More in News